Chemomab Therapeutics Ltd. (CMMB) at a glance

Chemomab Therapeutics Ltd. (CMMB) is a micro-cap Healthcare company. It trades at $2.43, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 56/100 overall. Its strongest dimension is Safety (90/100) and its weakest is Income (40/100). It is a relatively defensive holding with below-market volatility.

Price

$2.43

Market cap

$16.9M

P/E ratio

n/a

Dividend yield

None

Beta

0.66

52-week range

$1.35 to $3.86